1. Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
   Shilong Zhang et al, 2023, Oncology Reports CrossRef
2. Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control
   Mahmoud E. Youssef et al, 2023, International Journal of Molecular Sciences CrossRef
3. In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation
   Muhammad Hamid Siddique et al, 2023, Pharmaceuticals CrossRef
4. Type Disparity in Sodium–Glucose Cotransporter-2 Inhibitors in Incidences of Renal Cell Carcinoma: A Propensity-Score-Matched Cohort Study
   Tsung-Kun Lin et al, 2024, Cancers CrossRef
5. The Effect of Dapagliflozin on Heart Function in Animal Models of Cardiac Ischemia, A Systematic Review and Meta-analysis
   Tina Kianfar et al, 2025, Current Reviews in Clinical and Experimental Pharmacology CrossRef
6. cFLIPL alleviates myocardial ischemia‐reperfusion injury by regulating pyroptosis
   Dong Zhang et al, 2024, Cell Biology International CrossRef